AUSTIN, Texas–(BUSINESS WIRE)–Elligo
Health Research, an integrated research organization (IRO),
announces the launch of its innovative IntElligo Research Stack™
clinical technology. This standards-based technology platform, which
powers the System
of Accelerated Research (SOAR™) model, will be launched this month
as the eSource documentation tool at Elligo’s Research
Ready network of study sites.
”IntElligo can be set up per the study protocol in hours and easily
follows the workflow in any physician’s office,” said Jacylyn
Bodmer, Elligo’s chief information officer. “We are improving
data quality while relieving administrative burden at the research site
and enabling more patient-centric interactions. IntElligo also
facilitates remote monitoring, which results in faster source data
verification and financial payments to our physicians.”
“IntElligo bridges health care and research, leveraging global industry
standards from the start (CDISC PRM and CDASH), thus facilitating
aggregation and tabulation into CDISC SDTM, the required format for
regulatory eSubmissions to the FDA and Japan’s PMDA,” added Rebecca
Kush, Ph.D., Elligo’s chief scientific officer.
In addition, the technology provides real-time management financial
management, reports, and analytics across research sites; saves time and
preserves data integrity by eliminating transcription; and, achieves
true eSource. Furthermore, it creates the opportunity to transform
research through the SOAR™ model — expanding patient access and driving
efficiency by enabling direct data from source to submission.
“By uniting our Goes
Direct® approach with this technology and infrastructure
to support physicians, we are creating the ultimate solution for
clinical trial execution,” said John
Potthoff, Ph.D., Elligo CEO. “The IntElligo platform will
become a primary resource for our study sites, increasing the ability
for physicians to provide research as a care option and enabling more
patients to benefit.”
About Elligo
Elligo Health Research, an integrated research organization, accelerates
the development of new pharmaceutical, biotechnology, medical device,
and diagnostic products using our novel IntElligo Research Stack™
clinical technology and our Goes Direct® approach. We unite the
best clinical experts with the best research infrastructure — creating
the ultimate clinical trial solution. By maintaining the integrity of
the trusted patient and physician relationship and building global
communities of research that leverage electronic health records, we
ensure all patients have access to clinical trials as a care option.
Learn more at elligodirect.com.
Contacts
Jane Byram
SCORR Marketing
512.626.2758
jane@scorrmarketing.com